179
Views
17
CrossRef citations to date
0
Altmetric
Review

The ATTEMPTS delivery systems for macromolecular drugs

, , , , , & show all
Pages 1255-1266 | Published online: 01 Nov 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Michelle L Wegscheid, Ramin A Morshed, Yu Cheng & Maciej S Lesniak. (2014) The art of attraction: applications of multifunctional magnetic nanomaterials for malignant glioma. Expert Opinion on Drug Delivery 11:6, pages 957-975.
Read now
Xinke Zhang, Xue Zhang & Fengshan Wang. (2012) Intracellular transduction and potential of Tat PTD and its analogs: from basic drug delivery mechanism to application. Expert Opinion on Drug Delivery 9:4, pages 457-472.
Read now

Articles from other publishers (15)

Ülo LangelÜlo Langel. 2023. CPP, Cell-Penetrating Peptides. CPP, Cell-Penetrating Peptides 151 204 .
Ülo LangelÜlo Langel. 2019. CPP, Cell-Penetrating Peptides. CPP, Cell-Penetrating Peptides 157 193 .
Junxiao Ye, Meong Cheol Shin, Qiuling Liang, Huining He & Victor C. Yang. (2015) 15 years of ATTEMPTS: A macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting. Journal of Controlled Release 205, pages 58-69.
Crossref
Meong Cheol Shin, Jian Zhang, Kyoung Ah Min, Huining He, Allan E. David, Yongzhuo Huang & Victor C. Yang. (2015) PTD-Modified ATTEMPTS for Enhanced Toxin-based Cancer Therapy: An In Vivo Proof-of-Concept Study. Pharmaceutical Research.
Crossref
Yaping Wang, Yifan Jiang, Meng Zhang, Jiao Tan, Jianming Liang, Huixin Wang, Yaping Li, Huining He, Victor C. Yang & Yongzhuo Huang. (2014) Protease-Activatable Hybrid Nanoprobe for Tumor Imaging. Advanced Functional Materials 24:34, pages 5443-5453.
Crossref
Yosi Shamay, Lina Shpirt, Gonen Ashkenasy & Ayelet David. (2013) Complexation of Cell-Penetrating Peptide–Polymer Conjugates with Polyanions Controls Cells Uptake of HPMA Copolymers and Anti-tumor Activity. Pharmaceutical Research 31:3, pages 768-779.
Crossref
Jian Zhang, Meong Cheol Shin & Victor C. Yang. (2013) Magnetic Targeting of Novel Heparinized Iron Oxide Nanoparticles Evaluated in a 9L-glioma Mouse Model. Pharmaceutical Research 31:3, pages 579-592.
Crossref
Jian Zhang, Meong Cheol Shin, Allan E. David, Jie Zhou, Kyuri Lee, Huining He & Victor C. Yang. (2013) Long-Circulating Heparin-Functionalized Magnetic Nanoparticles for Potential Application as a Protein Drug Delivery Platform. Molecular Pharmaceutics 10:10, pages 3892-3902.
Crossref
Huining He, Allan David, Beata Chertok, Adam Cole, Kyuri Lee, Jian Zhang, Jianxin Wang, Yongzhuo Huang & Victor C. Yang. (2013) Magnetic Nanoparticles for Tumor Imaging and Therapy: A So-Called Theranostic System. Pharmaceutical Research 30:10, pages 2445-2458.
Crossref
Shahriar Absar, Suna Choi, Fakhrul Ahsan, Everardo Cobos, Victor C. Yang & Young M. Kwon. (2013) Preparation and characterization of anionic oligopeptide-modified tissue plasminogen activator for triggered delivery: An approach for localized thrombolysis. Thrombosis Research 131:3, pages e91-e99.
Crossref
Khalid A. Mohamedali, Gang Niu, Troy A. Luster, Philip E. Thorpe, Haokao Gao, Xiaoyuan Chen & Michael G. Rosenblum. (2012) Pharmacodynamics, tissue distribution, toxicity studies and antitumor efficacy of the vascular targeting fusion toxin VEGF121/rGel. Biochemical Pharmacology 84:11, pages 1534-1540.
Crossref
Shahriar Absar, Suna Choi, Victor C. Yang & Young M. Kwon. (2012) Heparin-triggered release of camouflaged tissue plasminogen activator for targeted thrombolysis. Journal of Controlled Release 157:1, pages 46-54.
Crossref
Mi-Ae Lyu, Yu (Joshua) Cao, Khalid A. Mohamedali & Michael G. Rosenblum. 2012. Protein Engineering for Therapeutics, Part A. Protein Engineering for Therapeutics, Part A 167 214 .
Arwyn T. Jones. 2010. Organelle-Specific Pharmaceutical Nanotechnology. Organelle-Specific Pharmaceutical Nanotechnology 263 288 .
Huining He, Weibing Dong, Junbo Gong, Jingkang Wang & Victor C. Yang. (2010) Developing macromolecular therapeutics: the future drug-of-choice. Frontiers of Chemical Engineering in China 4:1, pages 10-17.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.